Markets buzz as another mRNA biotech unicorn looks to carry home a record $800M IPO haul
That other messenger RNA biotech unicorn is looking to jump into Wall Street with an IPO that may seek a record $800 million and a valuation of some $4 billion.
Bankers are buzzing that Bank of America and JP Morgan have already been tapped for the IPO on behalf of BioNTech, a German biotech that has attracted considerable attention for its role as a leader in the mRNA field, according to a report in Reuters.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.